Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Real Benefits of Real-World Evidence in the Healthcare Industry - A Quantzig Whitepaper

Posted on: 09 Mar 18

Quantzig, a global analytics solutions provider, has announced the completion of their most recent whitepaper on the benefits of real-world evidence in the healthcare industry. Real world evidence studies are used to understand clinical practice patterns and epidemiology of diseases, and to make implications related to the product’s long-term safety, relative efficiency, and product differentiation strategies.

This press release features multimedia. View the full release here:


It is the real-world data that offers precise information associated with a patient’s treatment and its development. Even though real-world evidence based on real-world data is neither a solution nor a replacement for clinical trials, it is expected to bring significant changes to the healthcare industry. Also, we predicted improvements in the methodologies and regulatory sciences related to its use with the growing applications of RWE. Therefore, to help companies better understand the applications of RWE, Quantzig has listed some of the benefits of real-world evidence in the healthcare industry.

According to the real world evidence experts at Quantzig, “When insights derived from RWE are used aptly it may help to accelerate innovation in the healthcare sector & renovate patient care globally.”

Request a free demo to see how Quantzig’s solutions can help you.

Benefits of real-world evidence in the healthcare industry:

  • Better healthcare outcomes – The real-world data obtained from patient health records can be used to improve the quality of the healthcare services offered to the patients by all the healthcare organizations. Healthcare companies can also increase the efficiency of their drug development process with the aid of RWE-based data.
  • Offers new healthcare insights – RWE is collected from different sources of data and helps in obtaining many insights. For example, firms can learn that a slightly less efficient but suggestively cheap medicine is the most cost-effective option for a particular patient populace. RWE can also provide meaningful perceptions into disease epidemiology.
  • Increases ROI for pharma companies – RWE can help in speeding up the process of developing new drugs, provide provable evidence to payers and support pharma firm in distinguishing their brand in the healthcare industry. So, the insights offered by RWE delivers abundant benefits to pharmaceutical firms.
  • To read more, download FREE sample

Download the complete list of real benefits of real-world evidence in the healthcare industry whitepaper here:

Keyword – Healthcare industry

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on all of Quantzig’s services and the solutions they have provided to Fortune 500 clients across all industries, please contact us.

View source version on

Business Wire

Last updated on: 09/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.